We are live on ! Find out more
TCBPW

TC BioPharm (Holdings) plc Warrants
TCBPW

Delisted

TCBPW was delisted on the 21st of March, 2025.

Back to rankings

5 hedge funds and large institutions have $16.4K invested in TC BioPharm (Holdings) plc Warrants in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

50% less capital invested

Capital invested by funds: $32.7K → $16.4K (-$16.4K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$151
Name Holding Trade Value Shares
Change 		Change in
Stake
KC
1
Kepos Capital
New York
$10K – – –
NCM
2
Nantahala Capital Management
Connecticut
$5.18K – – –
AC
3
Armistice Capital
New York
$787 – – –
ACM
4
Altium Capital Management
New York
$393 – – –
UBS Group
5
UBS Group
Switzerland
$1 -$151 -4,079 -97%

TCBPW Hedge Fund Activity: Q3 2023 in Review

5 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in TC BioPharm (Holdings) plc Warrants (TCBPW) for Q3 2023, worth a combined $16.4K — down 50% from $32.7K a quarter earlier.

Fund positioning in TCBPW was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was UBS Group, cutting an estimated $151.

  • 5 institutional investors held TC BioPharm (Holdings) plc Warrants (TCBPW) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $16.4K of TC BioPharm (Holdings) plc Warrants stock for Q3 2023, down 50% quarter-over-quarter.
  • 0 funds opened new TC BioPharm (Holdings) plc Warrants positions in Q3 2023 and 0 closed out.
  • The largest TC BioPharm (Holdings) plc Warrants seller in Q3 2023 was UBS Group, an estimated $151 sold.

Based on aggregated 13F filings for Q3 2023.